Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Smart

Showing results (291-300 of 303) with videos related to

Pageof 31
Sort By:
American Journal of Hematology|February 9, 2024
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trialAlexandra Power-Hays, George A Tomlinson, Leon Tshilolo, et al.
British Journal of Haematology|July 6, 2021
Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemiaCharles T Quinn, Omar Niss, Min Dong, et al.
The Science of the Total Environment|December 23, 2019
Vegetation and longitudinal coarse sediment connectivity affect the ability of ecosystem restoration to reduce riverbank erosion and turbidity in drinking waterJoseph M McMahon, Jon M Olley, Andrew P Brooks, et al.
Blood|November 14, 2022
Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan AfricaPeter Olupot-Olupot, George Tomlinson, Thomas N Williams, et al.
The Science of the Total Environment|August 12, 2021
Increasing the cost-effectiveness of nutrient reduction targets using different spatial scalesMikołaj Czajkowski, Hans E Andersen, Gitte Blicher-Mathiesen, et al.
Diving and Hyperbaric Medicine|September 13, 2022
Hyperbaric Oxygen for Lower Limb Trauma (HOLLT): an international multi-centre randomised clinical trialIan L Millar, Folke G Lind, Karl-Åke Jansson, et al.
Ambio|January 14, 2014
Reduction of Baltic Sea nutrient inputs and allocation of abatement costs within the Baltic Sea catchmentFredrik Wulff, Christoph Humborg, Hans Estrup Andersen, et al.
British Journal of Haematology|October 15, 2024
Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan AfricaCatherine I Segbefia, Luke R Smart, Susan E Stuber, et al.
Acta Haematologica|August 17, 2022
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan AfricaLuke R Smart, Emmanuela E Ambrose, Georgina Balyorugulu, et al.
Blood Advances|September 30, 2025
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populationsAlexandra Power-Hays, Kathryn E McElhinney, Thomas N Williams, et al.
Pageof 31

Showing results (291-300 of 303) with videos related to

Sort By:
Pageof 31
American Journal of Hematology|February 9, 2024
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trialAlexandra Power-Hays, George A Tomlinson, Leon Tshilolo, et al.
British Journal of Haematology|July 6, 2021
Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemiaCharles T Quinn, Omar Niss, Min Dong, et al.
The Science of the Total Environment|December 23, 2019
Vegetation and longitudinal coarse sediment connectivity affect the ability of ecosystem restoration to reduce riverbank erosion and turbidity in drinking waterJoseph M McMahon, Jon M Olley, Andrew P Brooks, et al.
Blood|November 14, 2022
Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan AfricaPeter Olupot-Olupot, George Tomlinson, Thomas N Williams, et al.
The Science of the Total Environment|August 12, 2021
Increasing the cost-effectiveness of nutrient reduction targets using different spatial scalesMikołaj Czajkowski, Hans E Andersen, Gitte Blicher-Mathiesen, et al.
Diving and Hyperbaric Medicine|September 13, 2022
Hyperbaric Oxygen for Lower Limb Trauma (HOLLT): an international multi-centre randomised clinical trialIan L Millar, Folke G Lind, Karl-Åke Jansson, et al.
Ambio|January 14, 2014
Reduction of Baltic Sea nutrient inputs and allocation of abatement costs within the Baltic Sea catchmentFredrik Wulff, Christoph Humborg, Hans Estrup Andersen, et al.
British Journal of Haematology|October 15, 2024
Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan AfricaCatherine I Segbefia, Luke R Smart, Susan E Stuber, et al.
Acta Haematologica|August 17, 2022
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan AfricaLuke R Smart, Emmanuela E Ambrose, Georgina Balyorugulu, et al.
Blood Advances|September 30, 2025
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populationsAlexandra Power-Hays, Kathryn E McElhinney, Thomas N Williams, et al.
Pageof 31